| P50 | author | Tamás Freund | Q1003857 |
| | István Katona | Q38320341 |
| P2860 | cites work | Homer Binds TRPC Family Channels and Is Required for Gating of TRPC1 by IP3 Receptors | Q24295021 |
| | Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain | Q24299523 |
| | Brain monoglyceride lipase participating in endocannabinoid inactivation | Q24533828 |
| | Cannabinoid receptor localization in brain | Q24558751 |
| | Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects | Q24569799 |
| | Activity-dependent regulation of synapses by retrograde messengers | Q24614596 |
| | The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors | Q24617322 |
| | Arachidonic acid and the brain | Q24620380 |
| | DAG lipase activity is necessary for TRP channel regulation in Drosophila photoreceptors | Q24644031 |
| | TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons | Q24644177 |
| | Novel endogenous peptide agonists of cannabinoid receptors | Q24644673 |
| | A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol | Q24649418 |
| | Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid | Q24657423 |
| | A biosynthetic pathway for anandamide | Q24671032 |
| | [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor | Q24680848 |
| | Hemopressin is an inverse agonist of CB1 cannabinoid receptors | Q24683759 |
| | Understanding synapses: past, present, and future | Q26269897 |
| | Endocannabinoid signaling and long-term synaptic plasticity. | Q35679432 |
| | Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons | Q36018163 |
| | Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice | Q36020820 |
| | Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors | Q36447081 |
| | Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. | Q36452302 |
| | Opposing actions of endothelin-1 on glutamatergic transmission onto vasopressin and oxytocin neurons in the supraoptic nucleus | Q36601711 |
| | COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity | Q36677473 |
| | Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain | Q36727266 |
| | Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity | Q36734402 |
| | Homeostatic signaling: the positive side of negative feedback | Q36798818 |
| | Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors | Q36861457 |
| | Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons | Q28144567 |
| | Molecular characterization of a phospholipase D generating anandamide and its congeners | Q28186509 |
| | CB1 cannabinoid receptors and on-demand defense against excitotoxicity | Q28207143 |
| | Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells | Q28212245 |
| | Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor | Q28218654 |
| | Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 |
| | A second endogenous cannabinoid that modulates long-term potentiation | Q28248073 |
| | Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling | Q28253698 |
| | Identification and functional characterization of brainstem cannabinoid CB2 receptors | Q28276972 |
| | Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus | Q28286042 |
| | 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain | Q28290395 |
| | Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 |
| | Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides | Q28295481 |
| | Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 |
| | International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂ | Q28298445 |
| | Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice | Q28469322 |
| | Neuronal protease-activated receptor 1 drives synaptic retrograde signaling mediated by the endocannabinoid 2-arachidonoylglycerol | Q28511266 |
| | Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism | Q28571959 |
| | Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D | Q28581971 |
| | Activation of the TRPC1 cation channel by metabotropic glutamate receptor mGluR1 | Q28582069 |
| | The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum | Q28587112 |
| | Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system | Q28590486 |
| | Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice | Q28591248 |
| | mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis | Q28591542 |
| | Phospholipase C isozymes selectively couple to specific neurotransmitter receptors | Q28593039 |
| | The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission | Q28594648 |
| | Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 |
| | Determination and characterization of a cannabinoid receptor in rat brain | Q29618888 |
| | Forebrain-specific inactivation of Gq/G11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formation | Q30478061 |
| | Altered surface trafficking of presynaptic cannabinoid type 1 receptor in and out synaptic terminals parallels receptor desensitization | Q30484615 |
| | Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. | Q30492114 |
| | Endocannabinoid-dependent homeostatic regulation of inhibitory synapses by miniature excitatory synaptic activities. | Q30492857 |
| | Postsynaptic TRPV1 triggers cell type–specific long-term depression in the nucleus accumbens | Q30500199 |
| | Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging | Q30502227 |
| | Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus | Q36917918 |
| | Activation of GABAA receptors: views from outside the synaptic cleft. | Q37022454 |
| | TRPC3 channels are required for synaptic transmission and motor coordination | Q37099115 |
| | Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. | Q37216017 |
| | Endocannabinoid signaling as a synaptic circuit breaker in neurological disease | Q37262759 |
| | Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress | Q37276946 |
| | Transmembrane helical domain of the cannabinoid CB1 receptor | Q37282203 |
| | Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors | Q37285069 |
| | Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses | Q37288785 |
| | Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain | Q37312874 |
| | Diglyceride lipase: a pathway for arachidonate release from human platelets | Q37336055 |
| | Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain? | Q37337607 |
| | Natural products as tools for neuroscience: discovery and development of novel agents to treat drug abuse | Q37355904 |
| | Endocannabinoid-mediated control of synaptic transmission | Q37363621 |
| | Spine microdomains for postsynaptic signaling and plasticity | Q37425885 |
| | Molecular reconstruction of mGluR5a-mediated endocannabinoid signaling cascade in single rat sympathetic neurons. | Q37436040 |
| | Preferential localization of muscarinic M1 receptor on dendritic shaft and spine of cortical pyramidal cells and its anatomical evidence for volume transmission. | Q39753711 |
| | Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus | Q39757955 |
| | Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals. | Q39831177 |
| | Multiple pathways involved in the biosynthesis of anandamide | Q40106992 |
| | A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization. | Q40116679 |
| | A molecular basis of analgesic tolerance to cannabinoids. | Q40146609 |
| | Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function | Q40224903 |
| | Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells | Q40773784 |
| | Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. | Q40818985 |
| | Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. | Q41093128 |
| | Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway | Q41791622 |
| | Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells | Q41808335 |
| | The endocannabinoid system controls key epileptogenic circuits in the hippocampus | Q42065383 |
| | The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons | Q42110966 |
| | Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain | Q42479973 |
| | Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. | Q42528169 |
| | Endocannabinoids Potentiate Synaptic Transmission through Stimulation of Astrocytes | Q42870301 |
| | Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system | Q42882543 |
| | Good news for CB1 receptors: endogenous agonists are in the right place | Q42986826 |
| | Bimodal control of stimulated food intake by the endocannabinoid system. | Q43169799 |
| | Activation conditions for the induction of metabotropic glutamate receptor-dependent long-term depression in hippocampal CA1 pyramidal cells | Q43182541 |
| | Synaptic activation of kainate receptors gates presynaptic CB(1) signaling at GABAergic synapses | Q43191478 |
| | Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids | Q43251476 |
| | Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. | Q43570628 |
| | Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals | Q43574291 |
| | Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors | Q43715218 |
| | Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. | Q30606134 |
| | Drug discovery and natural products: end of an era or an endless frontier? | Q30866998 |
| | Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? | Q33211909 |
| | Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex | Q33293523 |
| | The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system | Q33323392 |
| | Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. | Q33716248 |
| | Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors | Q33717685 |
| | Homer 1a gates the induction mechanism for endocannabinoid-mediated synaptic plasticity | Q33744346 |
| | AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity | Q33784846 |
| | Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses | Q33814760 |
| | Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses | Q33940688 |
| | Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus | Q33996513 |
| | Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. | Q34025536 |
| | Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens | Q34032832 |
| | Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes | Q34048105 |
| | An endogenous cannabinoid (2-AG) is neuroprotective after brain injury | Q34093755 |
| | Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers | Q34199610 |
| | Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice | Q34203193 |
| | Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis | Q34234907 |
| | An endocannabinoid mechanism for stress-induced analgesia. | Q34428429 |
| | Chemical constituents of marijuana: the complex mixture of natural cannabinoids | Q34455944 |
| | Spine Ca2+ signaling in spike-timing-dependent plasticity. | Q34576681 |
| | Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus | Q34582789 |
| | Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 |
| | TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. | Q34684362 |
| | Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. | Q34691517 |
| | Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system | Q34745063 |
| | Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver | Q34794697 |
| | Diacylglycerol lipase-alpha and -beta control neurite outgrowth in neuro-2a cells through distinct molecular mechanisms | Q35080503 |
| | Cell-type-specific CCK2 receptor signaling underlies the cholecystokinin-mediated selective excitation of hippocampal parvalbumin-positive fast-spiking basket cells | Q35172234 |
| | Molecular composition of the endocannabinoid system at glutamatergic synapses. | Q35220762 |
| | Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes | Q35592076 |
| | COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation | Q35593070 |
| | Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. | Q35678770 |
| | Evidence for presynaptic cannabinoid CB(1) receptor-mediated inhibition of noradrenaline release in the guinea pig lung | Q43812206 |
| | Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. | Q43816494 |
| | Postsynaptic endocannabinoid release is critical to long-term depression in the striatum | Q43971441 |
| | 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain | Q44018878 |
| | The endogenous cannabinoid system controls extinction of aversive memories | Q44085607 |
| | Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability | Q44437517 |
| | n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice | Q44524041 |
| | Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels | Q44524443 |
| | Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors | Q44553567 |
| | Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents | Q44758240 |
| | Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus | Q44927481 |
| | Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. | Q44963304 |
| | The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice | Q45087565 |
| | The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling. | Q45240196 |
| | U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance. | Q45253911 |
| | Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo | Q45299326 |
| | Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. | Q46055962 |
| | Predominant expression of phospholipase Cbeta1 in telencephalic principal neurons and cerebellar interneurons, and its close association with related signaling molecules in somatodendritic neuronal elements | Q46273270 |
| | Requirement for CB1 but not GABAB receptors in the cholecystokinin mediated inhibition of GABA release from cholecystokinin expressing basket cells | Q46366299 |
| | Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. | Q46366644 |
| | Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. | Q46624652 |
| | Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. | Q46691853 |
| | Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. | Q46764070 |
| | Postsynaptic current mediated by metabotropic glutamate receptors in cerebellar Purkinje cells | Q47681459 |
| | Lysophosphoinositide-specific phospholipase C in rat brain synaptic plasma membranes | Q48146427 |
| | Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. | Q48217036 |
| | Afferent-specific innervation of two distinct AMPA receptor subtypes on single hippocampal interneurons | Q48240092 |
| | Retrograde regulation of GABA transmission by the tonic release of oxytocin and endocannabinoids governs postsynaptic firing. | Q48279730 |
| | Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. | Q48556515 |
| | Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization | Q48918978 |
| | Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex | Q48971057 |
| | Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal | Q49124925 |
| | GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. | Q52023779 |
| | Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception. | Q53577374 |
| | Glycine potentiates the NMDA response in cultured mouse brain neurons | Q59050531 |
| | Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus | Q59081310 |
| | Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells | Q61479730 |
| | A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain | Q64212085 |
| | The absolute configuration of δ1-tetrahydrocannabinol, the major active constituent of hashish | Q72255583 |
| | In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis | Q83389390 |
| | Endogenously generated 2-arachidonoylglycerol plays an inhibitory role in bombesin-induced activation of central adrenomedullary outflow in rats | Q83523096 |
| | Molecular and morphological configuration for 2-arachidonoylglycerol-mediated retrograde signaling at mossy cell-granule cell synapses in the dentate gyrus | Q84197041 |
| | Chemical basis of hashish activity | Q93803717 |
| P921 | main subject | endocannabinoids | Q10483908 |
| P304 | page(s) | 529-558 | |
| P577 | publication date | 2012-04-17 | |
| P1433 | published in | Annual Review of Neuroscience | Q15753632 |
| P1476 | title | Multiple functions of endocannabinoid signaling in the brain | |
| P478 | volume | 35 | |